400-920-2911 sales@csnpharm.cn
CAS No.: 867331-82-6
TG 100801 is the prodrug of TG 100572, which is a multi-targeted kinase inhibitor that inhibit select growth factor receptor tyrosine kinases and Src family kinases with IC50 values of 2/7/2/1/0.5 nM of VEGFR1/VEGFR2/FGFR1/Src/Fyn kianse respectively.
规格 | 价格 | 促销价格 | 库存 | 数量 |
---|
生物活性
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
---|---|---|---|---|---|
NCT00509548 | Macular Degeneration ... more >> Choroidal Neovascularization Collapse << | Phase 2 | Terminated | - | United States, Arizona ... more >> Retina Centers, PC Tucson, Arizona, United States, 85704 United States, California Retina-Vitreous Associates Medical Group Beverly Hills, California, United States, 90211 United States, Florida Center for Retina and Macular Disease Winter Haven, Florida, United States, 33880 United States, Massachusetts Ophthalmic Consultants of Boston Boston, Massachusetts, United States, 02114 United States, New York Vitreous-Retina-Macula Consultants of New York New York, New York, United States, 10022 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, South Dakota Black Hills Regional Eye Institute Rapid City, South Dakota, United States, 57701 United States, Texas Vitreoretinal Consultants Houston, Texas, United States, 77030 Collapse << |
NCT00414999 | Macular Degeneration ... more >> Diabetic Retinopathy Collapse << | Phase 1 | Completed | - | United States, Kansas ... more >> Quintiles Phase One Services, Inc. Lenexa, Kansas, United States, 66219 Collapse << |
实验方案
技术信息
CAS号 | 867331-82-6 | 储存条件 |
|
|
分子式 | C33H30ClN5O3 | 运输 | 蓝冰 | |
分子量 | 580.08 | 别名 |